|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
B-dependent mechanism
1 Life Science, National Taiwan University, Taipei, Taiwan; Institute of Zoology, National Taiwan University, Taipei, Taiwan
2 Institute of Zoology, National Taiwan University, Taipei, Taiwan
3 Life Science, National Taiwan University, Taipei, Taiwan
4 Institute of Molecular and Cellular Biology, National Taiwan University, Taipei, Taiwan
5 Institute of Biotechnology in Medicine, National Yang-Ming University, Taipei, Taiwan
6 Institute of Biochemistry, National Cheng Kung University, Tainan, Taiwan
* To whom correspondence should be addressed. E-mail: hsinyu{at}ntu.edu.tw.
Lysophosphatidic acid (LPA) and sphingosine 1-phosphate (S1P) are both low molecular weight lysophospholipid (LPL) ligands which are recognized by the Edg family of G protein-coupled receptors. In endothelial cells, these two ligands activate Edg receptors resulting in cell proliferation and cell migration. The intercellular adhesion molecule-1 (ICAM-1, CD54) is one of many cell adhesion molecules belonging to the immunoglobulin super family. Work illustrated in this article showed that LPA and S1P enhance ICAM-1 expression at both the mRNA and protein levels in human umbilical cord vein endothelial cells (HUVECs). This enhanced ICAM-1 expression in HUVECs was first observed at 2 h post-ligand treatment. Maximal expression appeared at 8 h post-ligand treatment, as detected by flow cytometry and Western blotting. Furthermore, the effects of S1P on ICAM-1 expression were shown to be concentration dependent. Prior treatment of HUVECs with pertussis toxin, a specific inhibitor of Gi, or PDTC and BAY11-7082, inhibitors of the NF
B pathway, or C. difficile Toxin B, an inhibitor of Rac, prevented the enhanced effect of S1P-induced ICAM-1 expression. However, pretreatment of HUVECs with C3, an inhibitor of rho, had no effect on S1P-enhanced ICAM-1 expression. In a static cell-cell adhesion assay system, pretreatment of LPL enhanced the adhesion between HUVECs and U937 cells, a human mononucleated cell line. The enhanced adhesion effect could be prevented by preincubation with a functional blocking antibody against human ICAM-1. These results suggest that LPLs released by activated platelets might enhance interactions of leukocytes with the endothelium through a Gi-, NF
B- and possibly Rac-dependent mechanism, thus facilitating wound-healing and inflammation processes.
This article has been cited by other articles:
![]() |
G. Daum, A. Grabski, and M.A. Reidy Sphingosine 1-Phosphate: A Regulator of Arterial Lesions Arterioscler Thromb Vasc Biol, October 1, 2009; 29(10): 1439 - 1443. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-L. Chang, M.-C. Ho, P.-H. Lee, C.-Y. Hsu, W.-P. Huang, and H. Lee S1P5 is required for sphingosine 1-phosphate-induced autophagy in human prostate cancer PC-3 cells Am J Physiol Cell Physiol, August 1, 2009; 297(2): C451 - C458. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Arita, Y. Hata, S. Nakao, T. Kita, M. Miura, S. Kawahara, S. Zandi, L. Almulki, F. Tayyari, H. Shimokawa, et al. Rho Kinase Inhibition by Fasudil Ameliorates Diabetes-Induced Microvascular Damage Diabetes, January 1, 2009; 58(1): 215 - 226. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. O. Apostolov, S. V. Shah, E. Ok, and A. G. Basnakian Carbamylated Low-Density Lipoprotein Induces Monocyte Adhesion to Endothelial Cells Through Intercellular Adhesion Molecule-1 and Vascular Cell Adhesion Molecule-1 Arterioscler Thromb Vasc Biol, April 1, 2007; 27(4): 826 - 832. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. T. Chiu, W. Y. Leung, M. P. Moyer, R. M. Strieter, and E. Rozengurt Protein kinase D2 mediates lysophosphatidic acid-induced interleukin 8 production in nontransformed human colonic epithelial cells through NF-{kappa}B Am J Physiol Cell Physiol, February 1, 2007; 292(2): C767 - C777. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |